W. Scott Harkonen
Nessuna posizione attualmente
Profilo
W.
Scott Harkonen served as President & CEO of InterMune, Inc. from 1999 to 2003.
He was also Chairman & CEO of CoTherix, Inc. and President & CEO of CoMentis, Inc. He held the position of SVP-Operations & Product Development at Connetics Corp.
from 1995 to 1999 and was Vice President at Nabi from 1991 to 1995.
Harkonen also served as a Director at Humanigen, Inc. and the Biotechnology Innovation Organization.
He holds an MBA from the University of California, Berkeley and undergraduate and doctorate degrees from the University of Minnesota.
Precedenti posizioni note di W. Scott Harkonen
| Società | Posizione | Fine |
|---|---|---|
| INTERMUNE INC | Presidente | 01/01/2003 |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Direttore operativo | 01/01/1999 |
Nabi
 Nabi Movies/EntertainmentConsumer Services Nabi engages in operating art and culture gallery. The company was founded on May 1, 1999 and is headquartered in Seoul, South Korea. | Corporate Officer/Principal | 01/01/1995 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direttore/Membro del Consiglio | - |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Presidente | - |
Formazione di W. Scott Harkonen
| University of California, Berkeley | Masters Business Admin |
| University of Minnesota | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HUMANIGEN, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Nabi
Nabi Movies/EntertainmentConsumer Services Nabi engages in operating art and culture gallery. The company was founded on May 1, 1999 and is headquartered in Seoul, South Korea. | Consumer Services |
CoMentis, Inc.
 CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- W. Scott Harkonen
